Neurim Pharmaceuticals

New Chemical Entities for Insomnia and Alzheimer's Disease

Startup

Neurim Pharmaceuticals is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 1991. New Chemical Entities for Insomnia and Alzheimer's Disease. Neurim Pharmaceuticals was founded by Nava Zisapel. Key investors include Prof. Nava & Yehuda Zisapel. The company has 11-50 employees. Core technologies: Materials & Substances.

The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

1
Rounds
1
Investors
2
Team
1991
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue EngineeringMaterials & Substances
At a Glance
Investors
Founders
In the News

6 articles covered by sources including www.prnewswire.com, www.spectrumnews.org, www.globes.co.il.

www.prnewswire.com · Sep 10, 2025
/CNW/ -- Neurim Pharmaceuticals is pleased to announce that Health Canada has granted marketing authorization* for Slenyto®, an Extended-release melatonin...
Read article ↗
Frequently Asked Questions
What does Neurim Pharmaceuticals do?

Neurim Pharmaceuticals is a drug discovery and development company focused on creating drugs for brain restoration and ongoing support. Its products are aimed at addressing insomnia, problems related to the central nervous system, and neurodegenerative diseases. The company's first approved drug is Circadin, a timed-release melatonin for insomnia. Circadin is commercially available in Europe, the AsiaPacific region, and the Middle East. The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended marketing authorization for Slenyto, a pediatric prolonged-release melatonin-coated tablet formulation for the treatment of children and adolescents with autism spectrum disorder and/or Smith-Magenis syndrome who suffer from insomnia.

Who founded Neurim Pharmaceuticals?

Neurim Pharmaceuticals was founded in 1991 by Nava Zisapel (Co-Founder CSO).

What sector is Neurim Pharmaceuticals in?

Neurim Pharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Biomaterials & Tissue Engineering, with core technologies in Materials & Substances. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Patients.

Where is Neurim Pharmaceuticals located?

Neurim Pharmaceuticals is based in HaBarzel Street 27, Tel Aviv, Israel, Center District. The company also has offices abroad.

View Full Profile Classic View Website ↗